KRYS

268.54

0.54% -1.46

시간 외 거래: 268.28 -0.26 -0.10%

Krystal Biotech Inc (KRYS)

개요 뉴스 가격 이력 옵션 체인 Financials KRYS 왜 하락? 토론 예측

전일 마감가:

$270.00

열려 있는:

$270.01

하루 거래량:

246.24K

Relative Volume:

0.85

시가총액:

$7.90B

수익:

$389.13M

순이익/손실:

$204.83M

주가수익비율:

39.24

EPS:

6.8443

순현금흐름:

$188.91M

1주 성능:

+1.64%

1개월 성능:

+8.61%

6개월 성능:

+39.15%

1년 성능:

+58.78%

1일 변동 폭

$262.40

$271.05

1주일 범위

$252.30

$275.75

52주 변동 폭

$122.80

$298.30

Krystal Biotech Inc Stock (KRYS) Company Profile

명칭

Krystal Biotech Inc

부문

Healthcare (1112)

산업

Biotechnology (621)

전화

(412) 586-5830

주소

2100 WHARTON STREET, PITTSBURGH, PA

직원

295

트위터

@KrystalBiotech

다음 수익 날짜

2024-11-04

최신 SEC 제출 서류

KRYS's Discussions on Twitter

Compare KRYS vs VRTX, REGN, ARGX, ALNY, ONC

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
KRYS Krystal Biotech Inc	268.54	7.95B	389.13M	204.83M	188.91M	6.8443
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-27	개시	Wolfe Research	Peer Perform
2026-01-06	업그레이드	Citigroup	Neutral → Buy
2025-03-05	개시	Jefferies	Buy
2024-08-06	다운그레이드	Citigroup	Buy → Neutral
2023-11-20	개시	Goldman	Buy
2023-10-24	개시	Cantor Fitzgerald	Overweight
2023-10-12	개시	Citigroup	Buy
2023-09-07	개시	Berenberg	Buy
2023-04-18	개시	Stifel	Buy
2023-02-28	업그레이드	Goldman	Neutral → Buy
2022-08-25	다운그레이드	Goldman	Buy → Neutral
2022-01-18	개시	BofA Securities	Buy
2021-07-20	업그레이드	Goldman	Neutral → Buy
2020-09-18	개시	B. Riley FBR	Buy
2020-06-04	개시	Evercore ISI	Outperform
2019-09-24	개시	Goldman	Neutral
2019-08-06	재확인	H.C. Wainwright	Buy
2019-06-24	재확인	Chardan Capital Markets	Buy
2019-06-24	재확인	H.C. Wainwright	Buy
2019-05-30	개시	Guggenheim	Buy
2018-09-11	개시	Cantor Fitzgerald	Overweight

모두보기

Krystal Biotech Inc 주식(KRYS)의 최신 뉴스

Apr 14, 2026

Krystal Biotech Inc stock (US5012681064): Is its gene therapy pipeline strong enough to unlock new u - AD HOC NEWS

Apr 14, 2026

Apr 12, 2026

Book value per share of Krystal Biotech Inc Unsponsored BDR – BMFBOVESPA:K1YS34 - TradingView — Track All Markets

Apr 12, 2026

Apr 11, 2026

Total equity of Krystal Biotech Inc Unsponsored BDR – BMFBOVESPA:K1YS34 - TradingView — Track All Markets

Apr 11, 2026

Krystal Biotech (HAM:4KB) Cyclically Adjusted Price-to-FCF : (As of Apr. 11, 2026) - GuruFocus

Apr 11, 2026

Krystal Biotech (NASDAQ:KRYS) - intelligentinvestor.com.au

Apr 11, 2026

Apr 10, 2026

Price-Driven Insight from (KRYS) for Rule-Based Strategy - Stock Traders Daily

Apr 10, 2026

Krystal Biotech (HAM:4KB) Gross Property, Plant and Equipment : €161.7 Mil (As of Dec. 2025) - GuruFocus

Apr 10, 2026

Krystal Biotech Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 10, 2026

Krystal Biotech Inc Phase 1/2 Clinical Trial of KB103 Final Update Call Transcript - GuruFocus

Apr 10, 2026

Krystal Biotech Inc (HAM:4KB) Competitors 2026 - GuruFocus

Apr 10, 2026

Krystal Biotech (HAM:4KB) Net Income (Continuing Operations) : €177.8 Mil (TTM As of Dec. 2025) - GuruFocus

Apr 10, 2026

Krystal Biotech Inc (HAM:4KB)Valuation Measures & Financial Statistics - GuruFocus

Apr 10, 2026

Krystal Biotech Inc (HAM:4KB) Stock HoldersInstitutional & Insider Ownership - GuruFocus

Apr 10, 2026

KRYS Technical Analysis | Trend, Signals & Chart Patterns | KRYSTAL BIOTECH INC (NASDAQ:KRYS) - ChartMill

Apr 10, 2026

Apr 08, 2026

BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $325 - Moomoo

Apr 08, 2026

Apr 07, 2026

Layoff Watch: Can Krystal Biotech Inc weather a recession2026 PreEarnings & Fast Gain Stock Trading Tips - baoquankhu1.vn

Apr 07, 2026

Could This Under-the-Radar Healthcare Stock Set You Up for Life? - AOL.com

Apr 07, 2026

Apr 04, 2026

KRYS | Krystal Biotech, Inc. Common Executive Compensation - Quiver Quantitative

Apr 04, 2026